Physician profile
Amber M Shemwell
NPI 1104958347
$5,999.58
in general payments reported to CMS, 2019-2025
42 companies · $637 in 2025
The $637 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,547 · 2020: $607 · 2021: $602 · 2022: $1,712 · 2023: $466 · 2024: $429 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,043.74 | 2019-2025 | |
| Abbvie INC. | $455.83 | 2019-2023 | |
| Astellas Pharma US INC | $334.22 | 2022-2025 | Veozah |
| Pfizer INC. | $271.24 | 2019-2024 | |
| Lupin INC. | $258.99 | 2019-2021 | |
| Daiichi Sankyo INC. | $227.26 | 2019-2022 | |
| Evofem Biosciences, INC. | $184.07 | 2022-2025 | Solosec, Phexx, Phexxi |
| Mayne Pharma Commercial LLC | $170.68 | 2022-2024 | |
| Minerva Surgical, INC | $168.14 | 2019-2022 | |
| Axonics, INC. | $163.35 | 2020-2022 | |
| Aspira Women'S Health INC | $153.44 | 2021-2022 | |
| Amgen INC. | $150.86 | 2019-2022 | |
| Coopersurgical, INC. | $113.06 | 2019-2024 | Endosee |
| Dexcom, INC. | $97.01 | 2025 | Dexcom G6 Transmitter |
| Ethicon US, LLC | $96.77 | 2021-2025 | Enseal, Surgicel Nu-Knit |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $95.30 | 2021 | |
| Hologic Sales and Service, LLC | $93.83 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Omni Hysteroscope |
| Novo Nordisk INC | $89.00 | 2023-2025 | Wegovy |
| Avion Pharmaceuticals | $83.71 | 2019-2023 | Balcoltra |
| Exeltis, USA INC. | $77.33 | 2024-2025 | Slynd |
| Sage Therapeutics, LLC | $74.74 | 2022-2025 | Zurzuvae |
| Organon LLC | $73.78 | 2022-2025 | Nexplanon, Jada System |
| Intuitive Surgical, INC. | $73.50 | 2019-2025 | |
| Amag Pharmaceuticals, INC. | $46.30 | 2019 | |
| Femselect INC. | $43.46 | 2023 | Enplace |
| Roche Diagnostics Corporation | $40.03 | 2019 | |
| Lilly USA, LLC | $32.39 | 2023-2024 | Zepbound |
| Pacira Pharmaceuticals Incorporated | $31.65 | 2021-2025 | Exparel |
| Smith+Nephew, INC. | $31.56 | 2024 | Pico 14, Renasys Touch, Pico 7 |
| Merck Sharp & Dohme LLC | $28.31 | 2023-2024 | Gardasil 9, Gardasil |
| Radius Health, INC. | $27.35 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.09 | 2020 | |
| Supernus Pharmaceuticals, INC. | $17.63 | 2025 | Qelbree |
| Myovant Sciences INC. | $16.60 | 2022 | |
| Acella Pharmaceuticals, LLC | $16.52 | 2025 | NP Thyroid 60 |
| Exact Sciences Corporation | $16.27 | 2023 | Cologuard Collection Kit |
| Shield Therapeutics INC | $15.07 | 2024 | |
| Duchesnay USA Incorporated | $14.19 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.85 | 2019 | |
| Allergan, INC. | $13.54 | 2019 | |
| Axsome Therapeutics, INC. | $13.48 | 2025 | Auvelity |
| Scynexis, INC. | $13.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Shemwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.